Literature DB >> 25772224

Dopaminergic regulation of olfactory type G-protein α subunit expression in the striatum.

I Ruiz-DeDiego1,2, J R Naranjo2,3, D Hervé4,5,6, R Moratalla1,2.   

Abstract

BACKGROUND: In rodents, the olfactory type G-protein α subunit (Gαolf) couples the dopamine D1 receptor (D1R) to adenylyl cyclase, triggering intracellular signaling and neuronal activation. In the striatum, Gαolf is enriched in the striosomes. Changes in Gαolf protein levels have been observed after dopamine depletion. However, the regulation of Gαolf expression by dopamine and dopamine receptors is not fully understood.
METHODS: To address this, Striatal Gαolf expression pattern was studied in wild-type and genetically engineered mice lacking D1R, D2R (D2 receptor), and downstream regulatory element antagonist modulator (DREAM) protein whose dopamine levels were manipulated. Dopamine depletion was accomplished by 6-hydroxydopamine (6-OHDA) or by Pitx3 ablation, and dopamine replacement by chronic levodopa (l-dopa). The Gαolf levels were analyzed by immunohistochemistry, Western blot, and real-time quantitative polymerase chain reaction (RT-qPCR).
RESULTS: Our results demostrate that Dopamine depletion or inactivation of D1R abolished the striosomal pattern of Gαolf expression and increased Gαolf protein levels. Dopamine replacement in wild-type lesioned mice reestablished both the expression pattern and protein levels, but paradoxically increased Gαolf messenger RNA (mRNA). In D1R(-/-) mice, dopamine depletion decreased striatal Gαolf expression, whereas l-dopa did not restore either Gαolf levels or its expression pattern. Inactivation of D2R or changes in the cAMP/PKA signaling pathway downstream of Gαolf did not modify its expression.
CONCLUSION: Our results show a homeostatic, negative regulation of Gαolf by dopamine and by D1R stimulation, which are also required for the striosomal Gαolf pattern. These results shed light on the regulation of Gαolf by dopamine signaling that could be involved in the pathophysiology of the maladaptive response to chronic l-dopa treatment in Parkinson's disease.
© 2015 International Parkinson and Movement Disorder Society.

Entities:  

Keywords:  AIMs; Parkinson's disease; dopaminergic receptors; l-dopa; striosomes

Mesh:

Substances:

Year:  2015        PMID: 25772224     DOI: 10.1002/mds.26197

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  13 in total

Review 1.  Nanomedicine to Overcome Current Parkinson's Treatment Liabilities: A Systematic Review.

Authors:  Gabriel Henrique Hawthorne; Marcelo Picinin Bernuci; Mariza Bortolanza; Vitor Tumas; Ana Carolina Issy; Elaine Del-Bel
Journal:  Neurotox Res       Date:  2016-08-31       Impact factor: 3.911

2.  A Selective Phosphodiesterase 10A Inhibitor Reduces L-Dopa-Induced Dyskinesias in Parkinsonian Monkeys.

Authors:  Goichi Beck; Shunsuke Maehara; Phat Ly Chang; Stella M Papa
Journal:  Mov Disord       Date:  2018-03-06       Impact factor: 10.338

3.  L-DOPA Reverses the Increased Free Amino Acids Tissue Levels Induced by Dopamine Depletion and Rises GABA and Tyrosine in the Striatum.

Authors:  Oscar Solís; Patricia García-Sanz; Antonio S Herranz; María-José Asensio; Rosario Moratalla
Journal:  Neurotox Res       Date:  2016-03-10       Impact factor: 3.911

Review 4.  Loss and remodeling of striatal dendritic spines in Parkinson's disease: from homeostasis to maladaptive plasticity?

Authors:  Rosa M Villalba; Yoland Smith
Journal:  J Neural Transm (Vienna)       Date:  2017-05-24       Impact factor: 3.575

5.  Selective Manipulation of G-Protein γ7 Subunit in Mice Provides New Insights into Striatal Control of Motor Behavior.

Authors:  Gloria Brunori; Oliver B Pelletier; Anna M Stauffer; Janet D Robishaw
Journal:  J Neurosci       Date:  2021-09-20       Impact factor: 6.167

6.  Differential Synaptic Remodeling by Dopamine in Direct and Indirect Striatal Projection Neurons in Pitx3-/- Mice, a Genetic Model of Parkinson's Disease.

Authors:  Luz M Suarez; Samuel Alberquilla; Jose R García-Montes; Rosario Moratalla
Journal:  J Neurosci       Date:  2018-02-26       Impact factor: 6.167

7.  Dopamine-Induced Changes in Gαolf Protein Levels in Striatonigral and Striatopallidal Medium Spiny Neurons Underlie the Genesis of l-DOPA-Induced Dyskinesia in Parkinsonian Mice.

Authors:  Ryoma Morigaki; Shinya Okita; Satoshi Goto
Journal:  Front Cell Neurosci       Date:  2017-02-10       Impact factor: 5.505

8.  Striatal Gαolf/cAMP Signal-Dependent Mechanism to Generate Levodopa-Induced Dyskinesia in Parkinson's Disease.

Authors:  Satoshi Goto
Journal:  Front Cell Neurosci       Date:  2017-11-21       Impact factor: 5.505

Review 9.  Olfactory Receptors in Non-Chemosensory Organs: The Nervous System in Health and Disease.

Authors:  Isidro Ferrer; Paula Garcia-Esparcia; Margarita Carmona; Eva Carro; Eleonora Aronica; Gabor G Kovacs; Alice Grison; Stefano Gustincich
Journal:  Front Aging Neurosci       Date:  2016-07-05       Impact factor: 5.750

10.  Genetic enhancement of Ras-ERK pathway does not aggravate L-DOPA-induced dyskinesia in mice but prevents the decrease induced by lovastatin.

Authors:  Irene Ruiz-DeDiego; Stefania Fasano; Oscar Solís; José-Rubén Garcia-Montes; José Brea; María I Loza; Riccardo Brambilla; Rosario Moratalla
Journal:  Sci Rep       Date:  2018-10-18       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.